Pharma rejects claims that it profited from H1N1 pandemic
This article was originally published in Scrip
Executive Summary
Europe's vaccine manufacturers have rejected accusations that they influenced policy makers, made undue profits and delivered dangerous vaccines in response to the H1N1 pandemic, a Council of Europe (CoE) public hearing heard on January 26th.